[Treatment of refractory cardiac insufficiency by peritoneal ultrafiltration. Literature review].
The management of heart failure that has become refractory to conventional drug treatment is an increasingly frequent problem for clinicians. Peritoneal dialysis, by ultrafiltration, is an effective method to treat refractory oedema, thereby improving the functional symptoms of these patients. The objective of this article is to review the data, of the literature and to define the results and indications of this treatment, which still remains and exceptional modality.
Lécluse
E
E
Service de Cardiologie, CHU, Côte de Nacre, 14033 Caen.
Ryckelink
J P
JP
Lobbedez
T
T
Saloux
E
E
Duarte
C
C
Devaluez
F
F
Hurault de Ligny
B H
BH
Valette
B
B
Hamon
M
M
Grollier
G
G
Potier
J C
JC
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000145:classification / Q000401:mortality / Q000628:therapy*; D006801:Humans; D018579:Patient Selection; D010530:Peritoneal Dialysis / Q000379:methods*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014462:Ultrafiltration / Q000379:methods*
D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004071:Digitalis Glycosides; D004232:Diuretics